{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:09:06Z","timestamp":1789614546252,"version":"build-2803163510"},"reference-count":325,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Autosomal dominant polycystic kidney disease (ADPKD), with an estimated genetic prevalence between 1:400 and 1:1,000 individuals, is the third most common cause of end stage kidney disease after diabetes mellitus and hypertension. Over the last 3\u00a0decades there has been great progress in understanding its pathogenesis. This allows the stratification of therapeutic targets into four levels, gene mutation and polycystin disruption, proximal mechanisms directly caused by disruption of polycystin function, downstream regulatory and signaling pathways, and non-specific pathophysiologic processes shared by many other diseases. Dysfunction of the polycystins, encoded by the PKD genes, is closely associated with disruption of calcium and upregulation of cyclic AMP and protein kinase A (PKA) signaling, affecting most downstream regulatory, signaling, and pathophysiologic pathways altered in this disease. Interventions acting on G protein coupled receptors to inhibit of 3\u2032,5\u2032-cyclic adenosine monophosphate (cAMP) production have been effective in preclinical trials and have led to the first approved treatment for ADPKD. However, completely blocking cAMP mediated PKA activation is not feasible and PKA activation independently from cAMP can also occur in ADPKD. Therefore, targeting the cAMP\/PKA\/CREB pathway beyond cAMP production makes sense. Redundancy of mechanisms, numerous positive and negative feedback loops, and possibly counteracting effects may limit the effectiveness of targeting downstream pathways. Nevertheless, interventions targeting important regulatory, signaling and pathophysiologic pathways downstream from cAMP\/PKA activation may provide additive or synergistic value and build on a strategy that has already had success. The purpose of this manuscript is to review the role of cAMP and PKA signaling and their multiple downstream pathways as potential targets for emergent therapies for ADPKD.<\/jats:p>","DOI":"10.3389\/fmolb.2022.981963","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:54:45Z","timestamp":1662080085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling"],"prefix":"10.3389","volume":"9","author":[{"given":"Xia","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1124\/jpet.114.213256","article-title":"Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injury","volume":"349","author":"Aihara","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.molcel.2016.03.037","article-title":"PKA regulates PINK1 stability and Parkin recruitment to damaged mitochondria through phosphorylation of MIC60","volume":"62","author":"Akabane","year":"2016","journal-title":"Mol. Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1210\/en.2008-0068","article-title":"Sustained elevated levels of circulating vasopressin selectively stimulate the proliferation of kidney tubular cells via the activation of V2 receptors","volume":"150","author":"Alonso","year":"2009","journal-title":"Endocrinology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.kint.2021.01.028","article-title":"The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1(RC\/RC) mouse model of autosomal dominant polycystic kidney disease","volume":"99","author":"Arroyo","year":"2021","journal-title":"Kidney Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1038\/s41598-020-61082-3","article-title":"A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells","volume":"10","author":"Asawa","year":"2020","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e49886","DOI":"10.15252\/embr.201949886","article-title":"Key phosphorylation sites in GPCRs orchestrate the contribution of beta-Arrestin 1 in ERK1\/2 activation","volume":"21","author":"Baidya","year":"2020","journal-title":"EMBO Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"716469","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: At the borders of autoimmunity and inflammation.","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"110992","DOI":"10.1016\/j.mce.2020.110992","article-title":"Everything you ever wanted to know about PKA regulation and its involvement in mammalian sperm capacitation","volume":"518","author":"Baro Graf","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cellsig.2018.03.002","article-title":"Adenylate cyclases: Receivers, transducers, and generators of signals","volume":"46","author":"Bassler","year":"2018","journal-title":"Cell. Signal."},{"key":"B10","doi-asserted-by":"publisher","first-page":"15054","DOI":"10.1038\/ncomms15054","article-title":"A new inhibitor of the beta-arrestin\/AP2 endocytic complex reveals interplay between GPCR internalization and signalling","volume":"8","author":"Beautrait","year":"2017","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2014.00071","article-title":"Regulation of the NF-\u03baB-Mediated transcription of inflammatory genes.","volume":"5","author":"Bhatt","year":"2014","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: Emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1210\/en.2004-0900","article-title":"Minireview: PRKAR1A: Normal and abnormal functions","volume":"145","author":"Bossis","year":"2004","journal-title":"Endocrinology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E287","DOI":"10.3390\/cells8040287","article-title":"Mitochondrial biogenesis and mitochondrial reactive oxygen species (ros): A complex relationship regulated by the cAMP\/PKA signaling pathway","volume":"8","author":"Bouchez","year":"2019","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000494739","article-title":"Genome-scale single nucleotide resolution analysis of DNA methylation in human autosomal dominant polycystic kidney disease","volume":"48","author":"Bowden","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fgene.2020.00348","article-title":"Extensive inter-cyst DNA methylation variation in autosomal dominant polycystic kidney disease revealed by genome scale sequencing","volume":"11","author":"Bowden","year":"2020","journal-title":"Front. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"21827","DOI":"10.1074\/jbc.M603952200","article-title":"Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation","volume":"281","author":"Brennan","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/j.ajkd.2021.06.026","article-title":"Metformin therapy in autosomal dominant polycystic kidney disease: A feasibility study","volume":"79","author":"Brosnahan","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1093\/ndt\/gfr432","article-title":"The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis","volume":"26","author":"Buchholz","year":"","journal-title":"Nephrol. Dial. Transpl."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/ki.2013.418","article-title":"Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells","volume":"85","author":"Buchholz","year":"2014","journal-title":"Kidney Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00109-010-0715-1","article-title":"Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion","volume":"89","author":"Buchholz","year":"","journal-title":"J. Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5732\/cjc.011.10132","article-title":"Apoptosis and the target genes of microRNA-21","volume":"30","author":"Buscaglia","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1038\/s41467-020-18104-5","article-title":"Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo","volume":"11","author":"Cabrita","year":"2020","journal-title":"Nat. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e29750","DOI":"10.7554\/eLife.29750","article-title":"cAMP signaling regulates DNA hydroxymethylation by augmenting the intracellular labile ferrous iron pool","volume":"6","author":"Camarena","year":"2017","journal-title":"Elife"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/j.1600-6143.2010.03152.x","article-title":"Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?","volume":"10","author":"Canaud","year":"2010","journal-title":"Am. J. Transpl."},{"key":"B28","doi-asserted-by":"publisher","first-page":"21819","DOI":"10.1073\/pnas.0911987106","article-title":"Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models","volume":"106","author":"Cao","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): A randomised, placebo-controlled, multicentre trial","volume":"382","author":"Caroli","year":"2013","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1096\/fj.201901739RR","article-title":"Increased mitochondrial fragmentation in polycystic kidney disease acts as a modifier of disease progression","volume":"34","author":"Cassina","year":"2020","journal-title":"FASEB J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"15803","DOI":"10.1073\/pnas.0808249105","article-title":"Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria","volume":"105","author":"Cereghetti","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tibs.2018.11.011","article-title":"New binding sites, new opportunities for GPCR drug discovery","volume":"44","author":"Chan","year":"2019","journal-title":"Trends biochem. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"21583","DOI":"10.1074\/jbc.C700083200","article-title":"Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology","volume":"282","author":"Chang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/hmg\/ddab340","article-title":"Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice","volume":"31","author":"Chang","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ki.2011.139","article-title":"Calcimimetics inhibit renal pathology in rodent nephronophthisis","volume":"80","author":"Chen","year":"2011","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1681\/ASN.2015030231","article-title":"2-Deoxy-d-Glucose ameliorates PKD progression","volume":"27","author":"Chiaravalli","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3390\/cells5010012","article-title":"The regulation of NF-\u03baB subunits by phosphorylation.","volume":"5","author":"Christian","year":"2016","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.1073\/pnas.1620454114","article-title":"Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease","volume":"114","author":"Ciolek","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.celrep.2017.08.012","article-title":"The functional impact of alternative splicing in cancer","volume":"20","author":"Climente-Gonzalez","year":"2017","journal-title":"Cell Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12913-020-4974-4","article-title":"The societal economic burden of autosomal dominant polycystic kidney disease in the United States","volume":"20","author":"Cloutier","year":"2020","journal-title":"BMC Health Serv. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/hmg\/ddz232","article-title":"AKT signaling promotes DNA damage accumulation and proliferation in polycystic kidney disease","volume":"29","author":"Conduit","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/sj.embor.7401062","article-title":"Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death","volume":"8","author":"Cribbs","year":"2007","journal-title":"EMBO Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.nefro.2019.03.004","article-title":"MAP3K kinases and kidney injury","volume":"39","author":"Cuarental","year":"2019","journal-title":"Nefrol. Engl. Ed."},{"key":"B45","doi-asserted-by":"publisher","first-page":"752117","DOI":"10.3389\/fphys.2021.752117","article-title":"Human sirtuin regulators: The \"success\" stories","volume":"12","author":"Curry","year":"2021","journal-title":"Front. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s004670050275","article-title":"Distribution of alpha-integrin subunits in fetal polycystic kidney diseases","volume":"11","author":"Daikha-Dahmane","year":"1997","journal-title":"Pediatr. Nephrol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1038\/s41467-019-12425-w","article-title":"Hydralazine targets cAMP-dependent protein kinase leading to sirtuin1\/5 activation and lifespan extension in C. elegans","volume":"10","author":"Dehghan","year":"2019","journal-title":"Nat. Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.15252\/embj.201796438","article-title":"MYC and tumor metabolism: Chicken and egg","volume":"36","author":"Dejure","year":"2017","journal-title":"EMBO J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1124\/pr.116.013078","article-title":"International union of basic and clinical pharmacology. CI. Structures and small molecule modulators of mammalian adenylyl cyclases","volume":"69","author":"Dessauer","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2017.05.041","article-title":"Shaping mitochondrial dynamics: The role of cAMP signalling","volume":"500","author":"Di Benedetto","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"102320","DOI":"10.1016\/j.ceca.2020.102320","article-title":"The basics of mitochondrial cAMP signalling: Where, when, why","volume":"93","author":"Di Benedetto","year":"2021","journal-title":"Cell Calcium"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1038\/s41598-018-23732-5","article-title":"Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells","volume":"8","author":"Di Mise","year":"2018","journal-title":"Sci. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e21874","DOI":"10.1096\/fj.202100774R","article-title":"Pre-clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease","volume":"35","author":"Di Mise","year":"2021","journal-title":"FASEB J."},{"key":"B54","first-page":"628","article-title":"Dual targeting of the G protein-coupled REceptors CaSR and VZR for treating autosomal dominant polycystic kidney disease","volume":"2019","author":"Di Mise","year":"2019","journal-title":"Amercian Soc. Nephrol. Kidney"},{"key":"B55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/362065a0","article-title":"Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities","volume":"362","author":"Dressler","year":"1993","journal-title":"Nature"},{"key":"B56","first-page":"463","article-title":"Pax2 in development and renal disease","volume":"43","author":"Dressler","year":"1999","journal-title":"Int. J. Dev. Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"20827","DOI":"10.1074\/jbc.C100195200","article-title":"Cyclic AMP-independent activation of protein kinase A by vasoactive peptides","volume":"276","author":"Dulin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol. Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1681\/ASN.2020020190","article-title":"Epithelial vasopressin type-2 receptors regulate myofibroblasts by a YAP-CCN2-dependent mechanism in polycystic kidney disease","volume":"31","author":"Dwivedi","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2215\/CJN.01520218","article-title":"Long-term effect of tolvaptan on renal function in autosomal dominant polycystic kidney disease","volume":"13","author":"Edwards","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.ekir.2020.06.002","article-title":"Biological efficacy and safety of niacinamide in patients with ADPKD","volume":"5","author":"El Ters","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"C522","DOI":"10.1152\/ajpcell.00163.2010","article-title":"c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation","volume":"301","author":"Elliott","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ki.2011.296","article-title":"Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation","volume":"81","author":"Fan","year":"2012","journal-title":"Kidney Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"C425","DOI":"10.1152\/ajpcell.00058.2015","article-title":"cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes","volume":"309","author":"Fang","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41467-018-03036-y","article-title":"Lkb1 deficiency confers glutamine dependency in polycystic kidney disease","volume":"9","author":"Flowers","year":"2018","journal-title":"Nat. Commun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1681\/ASN.2014100967","article-title":"Phosphoinositide 3-kinase-C2\u03b1 regulates polycystin-2 ciliary entry and protects against kidney cyst formation.","volume":"27","author":"Franco","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/0014-5793(86)81180-2","article-title":"Somatostatin and alpha 2-adrenergic agonists selectively inhibit vasopressin-induced cyclic AMP accumulation in MDCK cells","volume":"198","author":"Friedlander","year":"1986","journal-title":"FEBS Lett."},{"key":"B69","doi-asserted-by":"publisher","first-page":"22191","DOI":"10.1074\/jbc.M110364200","article-title":"New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP","volume":"277","author":"Fujita","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1073\/pnas.1109237109","article-title":"A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction","volume":"109","author":"Fusco","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ydbio.2012.01.014","article-title":"A protein kinase A and Wnt-dependent network regulating an intermediate stage in epithelial tubulogenesis during kidney development","volume":"364","author":"Gallegos","year":"2012","journal-title":"Dev. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1681\/ASN.2008090927","article-title":"Calcimimetic inhibits late-stage cyst growth in ADPKD","volume":"20","author":"Gattone","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev. Genet."},{"key":"B75","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.molcel.2011.12.005","article-title":"The cAMP\/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+)","volume":"44","author":"Gerhart-Hines","year":"2011","journal-title":"Mol. Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1007\/s00018-011-0757-8","article-title":"Cyclic AMP: A selective modulator of NF-\u03baB action","volume":"68","author":"Gerlo","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/genes9010009","article-title":"Signaling pathways driving aberrant splicing in cancer cells","volume":"9","author":"Goncalves","year":"2017","journal-title":"Genes (Basel)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1091\/mbc.12.2.255","article-title":"Cyclic AMP increases cell surface expression of functional Na, K-ATPase units in mammalian cortical collecting duct principal cells","volume":"12","author":"Gonin","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1053\/j.gastro.2010.04.010","article-title":"Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD","volume":"139","author":"Gradilone","year":"2010","journal-title":"Gastroenterology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/ndt\/gfw060","article-title":"Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease","volume":"32","author":"Grantham","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1046\/j.1523-1755.2003.00242.x","article-title":"Lillian jean kaplan international prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: A systems biology approach","volume":"64","author":"Grantham","year":"2003","journal-title":"Kidney Int."},{"key":"B82","doi-asserted-by":"publisher","first-page":"E39","DOI":"10.3390\/antiox10010039","article-title":"Protective role of Nrf2 in renal disease","volume":"10","author":"Guerrero-Hue","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"B84","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-416027-9.00002-4","article-title":"Functions of DNA methylation and hydroxymethylation in mammalian development","volume":"104","author":"Guibert","year":"2013","journal-title":"Curr. Top. Dev. Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e60684","DOI":"10.7554\/eLife.60684","article-title":"The heteromeric PC-1\/PC-2 polycystin complex is activated by the PC-1 N-terminus","volume":"9","author":"Ha","year":"2020","journal-title":"Elife"},{"key":"B86","doi-asserted-by":"publisher","first-page":"193","DOI":"10.29252\/rbmb.9.2.193","article-title":"Methylation of the PKD1 promoter inversely correlates with its expression in autosomal dominant polycystic kidney disease","volume":"9","author":"Hajirezaei","year":"2020","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1074\/jbc.M210621200","article-title":"Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells","volume":"278","author":"Hallows","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"F1223-F1231","DOI":"10.1152\/ajprenal.00697.2016","article-title":"Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the cpk mouse, a model of autosomal recessive polycystic kidney disease","volume":"313","author":"Hama","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B89","article-title":"Small-molecule allosteric activators of long-form PDE4 enzymes suppress cystogenesis in models of ADPKD [abstract]","volume":"2020","author":"Henderson","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","article-title":"Structure and dynamics of GPCR signaling complexes","volume":"25","author":"Hilger","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2215\/CJN.13661119","article-title":"Pansomatostatin agonist pasireotide long-acting release for patients with autosomal dominant polycystic kidney or liver disease with severe liver involvement: A randomized clinical trial","volume":"15","author":"Hogan","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1093\/ndt\/gfs152","article-title":"Somatostatin analog therapy for severe polycystic liver disease: Results after 2 years","volume":"27","author":"Hogan","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1681\/ASN.2013121312","article-title":"Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model","volume":"1","author":"Hopp","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"F261","DOI":"10.1152\/ajprenal.00345.2014","article-title":"Effects of hydration in rats and mice with polycystic kidney disease","volume":"308","author":"Hopp","year":"","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"E1342","DOI":"10.3390\/cells9061342","article-title":"Reactive oxygen species and redox signaling in chronic kidney disease","volume":"9","author":"Irazabal","year":"2020","journal-title":"Cells"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e00337-17","DOI":"10.1128\/MCB.00337-17","article-title":"Mitochondrial abnormality facilitates cyst formation in autosomal dominant polycystic kidney disease","volume":"37","author":"Ishimoto","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MNH.0000000000000556","article-title":"Nuclear factor erythroid 2-related factor 2 as a treatment target of kidney diseases","volume":"29","author":"Ito","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B100","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/FJC.0000000000000482","article-title":"G protein-coupled receptor signaling through beta-arrestin-dependent mechanisms","volume":"70","author":"Jean-Charles","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.bbadis.2014.06.001","article-title":"L-type calcium channel modulates cystic kidney phenotype","volume":"1842","author":"Jin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B102","doi-asserted-by":"publisher","first-page":"F479","DOI":"10.1152\/ajprenal.00329.2017","article-title":"Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway","volume":"315","author":"Jing","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"10856","DOI":"10.1038\/ncomms10856","article-title":"AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B","volume":"7","author":"Johanns","year":"2016","journal-title":"Nat. Commun."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/s0002-9440(10)63539-0","article-title":"Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: Role in increased cell adhesion and migration","volume":"163","author":"Joly","year":"2003","journal-title":"Am. J. Pathol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: Islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"B106","doi-asserted-by":"publisher","first-page":"110226","DOI":"10.1016\/j.cellsig.2021.110226","article-title":"A role for BET proteins in regulating basal, dopamine-induced and cAMP\/PKA-dependent transcription in rat striatal neurons","volume":"91","author":"Jones-Tabah","year":"2022","journal-title":"Cell. Signal."},{"key":"B107","doi-asserted-by":"publisher","first-page":"109703","DOI":"10.1016\/j.cellsig.2020.109703","article-title":"Targeting chloride transport in autosomal dominant polycystic kidney disease","volume":"73","author":"Jouret","year":"2020","journal-title":"Cell. Signal."},{"key":"B108","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12020-012-9634-y","article-title":"The evolutionary origin of the vasopressin\/V2-type receptor\/aquaporin axis and the urine-concentrating mechanism","volume":"42","author":"Juul","year":"2012","journal-title":"Endocrine"},{"key":"B109","doi-asserted-by":"publisher","first-page":"E1994","DOI":"10.3390\/ijms21061994","article-title":"Oxidative stress and mitochondrial abnormalities contribute to decreased endothelial nitric oxide synthase expression and renal disease progression in early experimental polycystic kidney disease","volume":"21","author":"Kahveci","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/jmcb\/mjw022","article-title":"A cAMP and CREB-mediated feed-forward mechanism regulates GSK3\u03b2 in polycystic kidney disease","volume":"8","author":"Kakade","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","article-title":"Structure-function of the G protein-coupled receptor superfamily","volume":"53","author":"Katritch","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"F96-F103","DOI":"10.1152\/ajprenal.1999.276.1.F96","article-title":"Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop","volume":"276","author":"Kim","year":"1999","journal-title":"Am. J. Physiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/ijms23021000","article-title":"Scaffolding of mitogen-activated protein kinase signaling by beta-arrestins","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"F726-F731","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease","volume":"310","author":"Kipp","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-05-0580","article-title":"A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues","volume":"65","author":"Kirschner","year":"2005","journal-title":"Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"F597","DOI":"10.1152\/ajprenal.00505.2013","article-title":"Lack of an effect of collecting duct-specific deletion of adenylyl cyclase 3 on renal Na+ and water excretion or arterial pressure","volume":"306","author":"Kittikulsuth","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"F1705","DOI":"10.1152\/ajprenal.00723.2012","article-title":"Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla","volume":"305","author":"Kortenoeven","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1074\/jbc.M111.303594","article-title":"Suppression of G\u03b1s synthesis by simvastatin treatment of vascular endothelial cells","volume":"287","author":"Kou","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B119","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11302-016-9532-5","article-title":"P2Y2R is a direct target of HIF-1\u03b1 and mediates secretion-dependent cyst growth of renal cyst-forming epithelial cells","volume":"12","author":"Kraus","year":"2016","journal-title":"Purinergic Signal."},{"key":"B120","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.kint.2018.06.008","article-title":"HIF-1\u03b1 promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease","volume":"94","author":"Kraus","year":"2018","journal-title":"Kidney Int."},{"key":"B121","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1159\/000488257","article-title":"Apabetalone mediated epigenetic modulation is associated with favorable kidney function and alkaline phosphatase profile in patients with chronic kidney disease","volume":"43","author":"Kulikowski","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"109594","DOI":"10.1016\/j.cellsig.2020.109594","article-title":"The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease","volume":"71","author":"Kurbegovic","year":"2020","journal-title":"Cell. Signal."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1681\/ASN.2015060634","article-title":"MicroRNA-21 aggravates cyst growth in a model of polycystic kidney disease","volume":"27","author":"Lakhia","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.kint.2020.02.012","article-title":"The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo","volume":"98","author":"Lannoy","year":"2020","journal-title":"Kidney Int."},{"key":"B125","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"B126","doi-asserted-by":"publisher","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: In vivo evidence from a pkd1-deletion model","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ebiom.2019.08.041","article-title":"Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease","volume":"47","author":"Leonhard","year":"2019","journal-title":"EBioMedicine"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1681\/ASN.2008030259","article-title":"Triptolide reduces cystogenesis in a model of ADPKD","volume":"19","author":"Leuenroth","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/ndt\/gfp777","article-title":"Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD","volume":"25","author":"Leuenroth","year":"2010","journal-title":"Nephrol. Dial. Transpl."},{"key":"B130","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B131","doi-asserted-by":"publisher","first-page":"16191","DOI":"10.1074\/jbc.M900393200","article-title":"In vivo selection of kinase-responsive RNA elements controlling alternative splicing","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1128\/MCB.20.24.9356-9363.2000","article-title":"Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta","volume":"20","author":"Li","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/bph.14558","article-title":"The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease","volume":"176","author":"Lian","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/ncomms2791","article-title":"Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth","volume":"4","author":"Lignitto","year":"2013","journal-title":"Nat. Commun."},{"key":"B135","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/ncb2209","article-title":"Control of PKA stability and signalling by the RING ligase praja2","volume":"13","author":"Lignitto","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1038\/emm.2015.98","article-title":"Isoproterenol increases histone deacetylase 6 expression and cell migration by inhibiting ERK signaling via PKA and Epac pathways in human lung cancer cells","volume":"48","author":"Lim","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2369-13-109","article-title":"Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease","volume":"13","author":"Liu","year":"","journal-title":"BMC Nephrol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1681\/ASN.2012050486","article-title":"A Pkd1-Fbn1 genetic interaction implicates TGF-beta signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease","volume":"25","author":"Liu","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"e49418","DOI":"10.1371\/journal.pone.0049418","article-title":"HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells","volume":"7","author":"Liu","year":"","journal-title":"PLoS One"},{"key":"B140","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1681\/ASN.2021010101","article-title":"Integrative cistromic and transcriptomic analyses identify CREB target genes in cystic renal epithelial cells","volume":"32","author":"Liu","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ajpath.2017.12.016","article-title":"Combination of a histone deacetylase 6 inhibitor and a somatostatin receptor agonist synergistically reduces hepatorenal cystogenesis in an animal model of polycystic liver disease","volume":"188","author":"Lorenzo Pisarello","year":"2018","journal-title":"Am. J. Pathol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1073\/pnas.0902661107","article-title":"Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-regulated apical chloride channels in cortical collecting duct","volume":"107","author":"Lu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B143","doi-asserted-by":"publisher","first-page":"101275","DOI":"10.1016\/j.redox.2019.101275","article-title":"GSK3\u03b2-mediated keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition","volume":"26","author":"Lu","year":"2019","journal-title":"Redox Biol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"eaba3613","DOI":"10.1126\/scitranslmed.aba3613","article-title":"Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1073\/pnas.041604898","article-title":"Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds","volume":"98","author":"Luttrell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1681\/ASN.2006030295","article-title":"Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na(+), K(+), 2Cl(-) Co-transporter-dependent cystic dilation","volume":"17","author":"Magenheimer","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"109468","DOI":"10.1016\/j.cellsig.2019.109468","article-title":"The PI3K\/Akt\/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium","volume":"66","author":"Margaria","year":"2020","journal-title":"Cell. Signal."},{"key":"B149","doi-asserted-by":"publisher","first-page":"e00048","DOI":"10.1128\/MCB.00048-20","article-title":"Differential activation of P-TEFb complexes in the development of cardiomyocyte hypertrophy following activation of distinct G protein-coupled receptors","volume":"40","author":"Martin","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"109637","DOI":"10.1016\/j.cellsig.2020.109637","article-title":"Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation","volume":"72","author":"Maser","year":"2020","journal-title":"Cell. Signal."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/hep.29284","article-title":"TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate\/G\u03b1s signaling","volume":"66","author":"Masyuk","year":"2017","journal-title":"Hepatology"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3', 5'-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"B153","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/hep.26140","article-title":"Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases","volume":"58","author":"Masyuk","year":"2013","journal-title":"Hepatology"},{"key":"B154","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35085068","article-title":"Transcriptional regulation by the phosphorylation-dependent factor CREB","volume":"2","author":"Mayr","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1001\/jama.2018.15870","article-title":"Effect of lanreotide on kidney function in patients with autosomal dominant polycystic kidney disease: The DIPAK 1 randomized clinical trial","volume":"320","author":"Meijer","year":"2018","journal-title":"JAMA"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab134.001","article-title":"Randomized, placebo-controlled, phase 3b trial of tolvaptan in the treatment of children and adolescents with autosomal dominant polycystic kidney disease (adpkd): 1-year data","volume":"36","author":"Mekahli","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"B157","doi-asserted-by":"publisher","first-page":"e2104578","DOI":"10.1002\/advs.202104578","article-title":"cAMP-induced nuclear condensation of CRTC2 promotes transcription elongation and cystogenesis in autosomal dominant polycystic kidney disease","volume":"9","author":"Mi","year":"2022","journal-title":"Adv. Sci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1038\/sj.emboj.7600275","article-title":"Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9\/cyclin T) inhibitor","volume":"23","author":"Michels","year":"2004","journal-title":"EMBO J."},{"key":"B159","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"B160","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1083\/jcb.201511036","article-title":"Metabolic regulation of mitochondrial dynamics","volume":"212","author":"Mishra","year":"2016","journal-title":"J. Cell Biol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1042\/BJ20101104","article-title":"Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase\/fructose-2, 6-bisphosphatase 2 in prostate cancer cells","volume":"433","author":"Moon","year":"2011","journal-title":"Biochem. J."},{"key":"B162","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B163","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","article-title":"mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation","volume":"18","author":"Morita","year":"2013","journal-title":"Cell Metab."},{"key":"B164","doi-asserted-by":"publisher","first-page":"re4","DOI":"10.1126\/scisignal.122re4","article-title":"Pharmacological PKA inhibition: All may not be what it seems","volume":"1","author":"Murray","year":"2008","journal-title":"Sci. Signal."},{"key":"B165","doi-asserted-by":"publisher","first-page":"F1166","DOI":"10.1152\/ajprenal.00196.2007","article-title":"Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL","volume":"293","author":"Mutig","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat","volume":"17","author":"Nagao","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/sj.ki.5002629","article-title":"Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy\/+ rat","volume":"73","author":"Nagao","year":"2008","journal-title":"Kidney Int."},{"key":"B168","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1248\/bpb.24.897","article-title":"Histopathological study of kidney abnormalities in an experimental SIADH rat model and its application to the evaluation of the pharmacologic profile of VP-343, a selective vasopressin V2 receptor antagonist","volume":"24","author":"Naito","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"B169","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bcp.2018.05.005","article-title":"Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion","volume":"154","author":"Nantavishit","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"E128","DOI":"10.3390\/cells9010128","article-title":"Cyclic AMP regulates key features of macrophages via PKA: Recruitment, reprogramming and efferocytosis","volume":"9","author":"Negreiros-Lima","year":"2020","journal-title":"Cells"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/embor.2011.151","article-title":"CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability","volume":"12","author":"Noriega","year":"2011","journal-title":"EMBO Rep."},{"key":"B172","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s1097-2765(03)00038-8","article-title":"The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase","volume":"11","author":"North","year":"2003","journal-title":"Mol. Cell"},{"key":"B173","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1073\/pnas.1822113116","article-title":"Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases","volume":"116","author":"Omar","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"F608","DOI":"10.1152\/ajprenal.00248.2005","article-title":"cAMP increases surface expression of NKCC2 in rat thick ascending limbs: role of VAMP","volume":"290","author":"Ortiz","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00418-009-0588-y","article-title":"Doxycycline accelerates renal cyst growth and fibrosis in the pcy\/pcy mouse model of type 3 nephronophthisis, a form of recessive polycystic kidney disease","volume":"132","author":"Osten","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1006\/dbio.2000.9618","article-title":"Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease","volume":"219","author":"Ostom","year":"2000","journal-title":"Dev. Biol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"B179","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.1074\/jbc.M112.432377","article-title":"Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner","volume":"288","author":"Padmanabhan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B180","doi-asserted-by":"publisher","first-page":"109634","DOI":"10.1016\/j.cellsig.2020.109634","article-title":"A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling","volume":"72","author":"Padovano","year":"2020","journal-title":"Cell. Signal."},{"key":"B181","doi-asserted-by":"publisher","first-page":"16773","DOI":"10.1074\/jbc.RA120.015400","article-title":"Allosteric activation of proto-oncogene kinase Src by GPCR-beta-arrestin complexes","volume":"295","author":"Pakharukova","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B182","doi-asserted-by":"publisher","first-page":"24939","DOI":"10.1074\/jbc.273.38.24939","article-title":"Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf","volume":"273","author":"Papin","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.05.028","article-title":"Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease","volume":"2022","author":"Parnell","year":"2022","journal-title":"Kidney Int."},{"key":"B184","doi-asserted-by":"publisher","first-page":"F27","DOI":"10.1152\/ajprenal.00298.2021","article-title":"Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model","volume":"322","author":"Pastor-Soler","year":"2022","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.devcel.2007.09.004","article-title":"The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex","volume":"13","author":"Patel","year":"2007","journal-title":"Dev. Cell"},{"key":"B186","doi-asserted-by":"publisher","first-page":"10765","DOI":"10.1073\/pnas.1301693110","article-title":"miR-17\u223c92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease","volume":"110","author":"Patel","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz106.FP117","article-title":"Safety and efficacy of bardoxolone methyl in patients with rare chronic kidney diseases","volume":"34","author":"Pergola","year":"2019","journal-title":"Nephrol. Dial. Transpl."},{"key":"B188","doi-asserted-by":"publisher","first-page":"e1002777","DOI":"10.1371\/journal.pmed.1002777","article-title":"Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (aladin 2): A randomized, double-blind, placebo-controlled, multicenter trial","volume":"16","author":"Perico","year":"2019","journal-title":"PLoS Med."},{"key":"B189","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2021.06.013","article-title":"Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)","volume":"100","author":"Perrone","year":"2021","journal-title":"Kidney Int."},{"key":"B190","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/pr.116.013367","article-title":"The diverse roles of arrestin scaffolds in G protein-coupled receptor signaling","volume":"69","author":"Peterson","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1681\/ASN.2015010047","article-title":"Phosphodiesterase isoform regulation of cell proliferation and fluid secretion in autosomal dominant polycystic kidney disease","volume":"27","author":"Pinto","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"F1412","DOI":"10.1152\/ajprenal.00692.2011","article-title":"Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells","volume":"303","author":"Pinto","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"109495","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2020","journal-title":"Cell. Signal."},{"key":"B194","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1753425920975082","article-title":"cAMP levels regulate macrophage alternative activation marker expression","volume":"27","author":"Polumuri","year":"2021","journal-title":"Innate Immun."},{"key":"B195","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.kint.2016.03.020","article-title":"\u03b23 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function","volume":"90","author":"Procino","year":"2016","journal-title":"Kidney Int."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1681\/ASN.2011030277","article-title":"c-Met and NF-\u03baB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease","volume":"23","author":"Qin","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmet.2021.03.024","article-title":"A methionine-Mettl3-N(6)-methyladenosine axis promotes polycystic kidney disease","volume":"33","author":"Ramalingam","year":"2021","journal-title":"Cell Metab."},{"key":"B198","doi-asserted-by":"publisher","first-page":"109548","DOI":"10.1016\/j.cellsig.2020.109548","article-title":"Modulation of polycystic kidney disease by non-coding RNAs","volume":"71","author":"Ramalingam","year":"2020","journal-title":"Cell. Signal."},{"key":"B199","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1681\/ASN.2016111235","article-title":"Integrin-linked kinase signaling promotes cyst growth and fibrosis in polycystic kidney disease","volume":"28","author":"Raman","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"EVIDoa2100021","DOI":"10.1056\/EVIDoa2100021","article-title":"Prescribed water intake in autosomal dominant polycystic kidney disease","volume":"1","author":"Rangan","year":"2022","journal-title":"NEJM Evid."},{"key":"B201","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1681\/ASN.2009060672","article-title":"GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity","volume":"21","author":"Rao","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2020.3308","article-title":"Effect of apabetalone added to standard therapy on major adverse cardiovascular events in patients with recent acute coronary syndrome and type 2 diabetes: A randomized clinical trial","volume":"323","author":"Ray","year":"2020","journal-title":"JAMA"},{"key":"B203","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1681\/ASN.2013010077","article-title":"Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease","volume":"25","author":"Rees","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2015.00177","article-title":"A dynamic interface between ubiquitylation and cAMP signaling","volume":"6","author":"Rinaldi","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"e0146654","DOI":"10.1371\/journal.pone.0146654","article-title":"Inhibition of aerobic glycolysis attenuates disease progression in polycystic kidney disease","volume":"11","author":"Riwanto","year":"2016","journal-title":"PLoS One"},{"key":"B206","doi-asserted-by":"publisher","first-page":"F78","DOI":"10.1152\/ajprenal.00397.2011","article-title":"Collecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice","volume":"302","author":"Roos","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1749-6632.2002.tb04327.x","article-title":"Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues","volume":"968","author":"Rosenberg","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B208","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat. Med."},{"key":"B209","doi-asserted-by":"publisher","first-page":"e0209186","DOI":"10.1371\/journal.pone.0209186","article-title":"Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease","volume":"14","author":"Sagar","year":"2019","journal-title":"PLoS One"},{"key":"B210","doi-asserted-by":"publisher","first-page":"E3166","DOI":"10.3390\/cancers12113166","article-title":"Targeting CREB in cancer therapy: A key candidate or one of many? An update","volume":"12","author":"Sapio","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B211","doi-asserted-by":"publisher","first-page":"G464","DOI":"10.1152\/ajpgi.00120.2020","article-title":"Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease","volume":"320","author":"Sato","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B212","doi-asserted-by":"crossref","DOI":"10.1101\/2022.01.31.477690","volume-title":"Evaluation of PRKACA as a therapeutic target for fibrolamellar carcinoma","author":"Schalm","year":"2022"},{"key":"B213","doi-asserted-by":"publisher","first-page":"e15058","DOI":"10.14814\/phy2.15058","article-title":"\u03b23 adrenergic receptor as potential therapeutic target in ADPKD","volume":"9","author":"Schena","year":"2021","journal-title":"Physiol. Rep."},{"key":"B214","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.isci.2022.104359","article-title":"Loss of Polycystin-1 causes cAMP-dependent switch from tubule to cyst formation","volume":"25","author":"Scholz","year":"2022","journal-title":"iScience"},{"key":"B215","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1681\/ASN.2018010039","article-title":"Lipid peroxidation drives renal cyst growth in vitro through activation of TMEM16A","volume":"30","author":"Schreiber","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B216","first-page":"629","article-title":"Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease","volume":"53","author":"Seeman","year":"2004","journal-title":"Physiol. Res."},{"key":"B217","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B218","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: The histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2005121298","article-title":"A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease","volume":"17","author":"Shannon","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1074\/jbc.M506576200","article-title":"beta-arrestin-dependent, G protein-independent ERK1\/2 activation by the beta2 adrenergic receptor","volume":"281","author":"Shenoy","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"B222","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41416-021-01321-0","article-title":"Achieving clinical success with BET inhibitors as anti-cancer agents","volume":"124","author":"Shorstova","year":"2021","journal-title":"Br. J. Cancer"},{"key":"B224","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1038\/sj.onc.1208159","article-title":"Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis","volume":"23","author":"Silva","year":"2004","journal-title":"Oncogene"},{"key":"B225","doi-asserted-by":"publisher","first-page":"D678","DOI":"10.2741\/skalhegg","article-title":"Specificity in the cAMP\/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA","volume":"5","author":"Skalhegg","year":"2000","journal-title":"Front. Biosci."},{"key":"B226","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1021\/jm200505e","article-title":"Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease","volume":"54","author":"Snyder","year":"2011","journal-title":"J. Med. Chem."},{"key":"B227","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/dvdy.10296","article-title":"Local activation of protein kinase A inhibits morphogenetic movements during Xenopus gastrulation","volume":"227","author":"Song","year":"2003","journal-title":"Dev. Dyn."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/ndt\/gfx349","article-title":"Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease","volume":"33","author":"Soomro","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"B229","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1002\/hep.25872","article-title":"Cyclic AMP\/PKA-dependent paradoxical activation of Raf\/MEK\/ERK signaling in polycystin-2 defective mice treated with sorafenib","volume":"56","author":"Spirli","year":"2012","journal-title":"Hepatology"},{"key":"B230","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"B231","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1093\/hmg\/ddl428","article-title":"Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease","volume":"15","author":"Stayner","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B232","doi-asserted-by":"publisher","first-page":"F859","DOI":"10.1152\/ajprenal.00109.2009","article-title":"Characterization of vasopressin-responsive collecting duct adenylyl cyclases in the mouse","volume":"298","author":"Strait","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"109639","DOI":"10.1016\/j.cellsig.2020.109639","article-title":"STAT signaling in polycystic kidney disease","volume":"72","author":"Strubl","year":"2020","journal-title":"Cell. Signal."},{"key":"B234","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1681\/ASN.V95903","article-title":"Chloride and fluid secretion in polycystic kidney disease","volume":"9","author":"Sullivan","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000499368","article-title":"Histone deacetylase inhibitors reduce cysts by activating autophagy in polycystic kidney disease","volume":"5","author":"Sun","year":"","journal-title":"Kidney Dis."},{"key":"B236","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/iub.1601","article-title":"TRAF3 delays cyst formation induced by NF-\u03baB signaling","volume":"69","author":"Sun","year":"2017","journal-title":"IUBMB Life"},{"key":"B237","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s10620-020-06229-y","article-title":"Androgen receptor stimulates hexokinase 2 and induces glycolysis by PKA\/CREB signaling in hepatocellular carcinoma","volume":"66","author":"Sun","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"B238","doi-asserted-by":"publisher","first-page":"eaaw3593","DOI":"10.1126\/sciadv.aaw3593","article-title":"Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease","volume":"5","author":"Sun","year":"","journal-title":"Sci. Adv."},{"key":"B239","first-page":"765A","article-title":"Phosphodiesterase modulation of renal cystogenesis, and effects of PKD2 on development of lateral line hair cells","volume":"2016","author":"Sussman","year":"2016","journal-title":"Am. Soc. Nephrol. Kidney Week"},{"key":"B240","doi-asserted-by":"publisher","first-page":"109649","DOI":"10.1016\/j.cellsig.2020.109649","article-title":"Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling","volume":"72","author":"Sussman","year":"2020","journal-title":"Cell. Signal."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00403-004-0478-z","article-title":"Cyclic AMP differentially regulates cell proliferation of normal human keratinocytes through ERK activation depending on the expression pattern of B-Raf","volume":"296","author":"Takahashi","year":"2004","journal-title":"Arch. Dermatol. Res."},{"key":"B243","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1093\/hmg\/ddr338","article-title":"Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways","volume":"20","author":"Takakura","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B244","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B245","doi-asserted-by":"publisher","first-page":"e21897","DOI":"10.1096\/fj.202100843R","article-title":"The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model","volume":"35","author":"Talbi","year":"2021","journal-title":"FASEB J."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1681\/ASN.2013091026","article-title":"The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation","volume":"25","author":"Talbot","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/ki.2014.427","article-title":"Glycogen synthase kinase-3\u03b2 promotes cyst expansion in polycystic kidney disease","volume":"87","author":"Tao","year":"2015","journal-title":"Kidney Int."},{"key":"B248","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00021.2003","article-title":"Localized effects of cAMP mediated by distinct routes of protein kinase A","volume":"84","author":"Tasken","year":"2004","journal-title":"Physiol. Rev."},{"key":"B249","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1074\/jbc.M508778200","article-title":"Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase","volume":"281","author":"Taurin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B250","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1681\/ASN.2016111232","article-title":"Bosutinib versus placebo for autosomal dominant polycystic kidney disease","volume":"28","author":"Tesar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.tips.2018.08.003","article-title":"Therapeutic targeting of endosomal G-protein-coupled receptors","volume":"39","author":"Thomsen","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"B252","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11083","article-title":"A unifying model for mTORC1-mediated regulation of mRNA translation","volume":"485","author":"Thoreen","year":"2012","journal-title":"Nature"},{"key":"B253","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B254","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ndt\/gfx043","article-title":"Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: The TEMPO 4:4 trial","volume":"33","author":"Torres","year":"","journal-title":"Nephrol. Dial. Transpl."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B256","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.ekir.2021.05.037","article-title":"Tolvaptan in ADPKD patients with very low kidney function","volume":"6","author":"Torres","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"B257","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJMc1716478","article-title":"Tolvaptan in later-stage polycystic kidney disease","volume":"378","author":"Torres","year":"","journal-title":"N. Engl. J. Med."},{"key":"B258","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat. Med."},{"key":"B259","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ki.1987.34","article-title":"Functional adaptation of thick ascending limb and internephron heterogeneity to urine concentration","volume":"31","author":"Trinh-Trang-Tan","year":"1987","journal-title":"Kidney Int."},{"key":"B261","doi-asserted-by":"publisher","first-page":"e00200-19","DOI":"10.1128\/MCB.00200-19","article-title":"CREB promotes beta cell gene expression by targeting its coactivators to tissue-specific enhancers","volume":"39","author":"Van de Velde","year":"2019","journal-title":"Mol. Cell. Biol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: A randomized, double-blind, placebo-controlled trial","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"B263","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B264","first-page":"457","article-title":"Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: A histochemical study","volume":"1","author":"Verani","year":"1988","journal-title":"Mod. Pathol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"15054","DOI":"10.1074\/jbc.RA120.013322","article-title":"Induction of UCP1 and thermogenesis by a small molecule via AKAP1\/PKA modulation","volume":"295","author":"Vergnes","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B266","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1440-1797.2007.00811.x","article-title":"Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease","volume":"12","author":"Wahl","year":"2007","journal-title":"Nephrol. Carlt."},{"key":"B267","doi-asserted-by":"publisher","first-page":"31515","DOI":"10.1074\/jbc.274.44.31515","article-title":"Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor","volume":"274","author":"Walker","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B268","doi-asserted-by":"publisher","first-page":"F1463","DOI":"10.1152\/ajprenal.90266.2008","article-title":"Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor","volume":"295","author":"Wallace","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/ki.2013.488","article-title":"Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease","volume":"85","author":"Wallace","year":"2014","journal-title":"Kidney Int."},{"key":"B270","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B271","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.kint.2017.08.005","article-title":"Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease","volume":"93","author":"Wang","year":"2018","journal-title":"Kidney Int."},{"key":"B272","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1159\/000500667","article-title":"Effect of a vasopressin V2 receptor antagonist on polycystic kidney disease development in a rat model","volume":"49","author":"Wang","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"B274","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ndt\/gfn527","article-title":"Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease","volume":"24","author":"Wang","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"B275","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1681\/ASN.2021081125","article-title":"Protein kinase A downregulation delays the development and progression of polycystic kidney disease","volume":"33","author":"Wang","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"B276","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ki.2009.438","article-title":"Cyclic nucleotide signaling in polycystic kidney disease","volume":"77","author":"Wang","year":"2010","journal-title":"Kidney Int."},{"key":"B277","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease","volume":"19","author":"Wang","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"B278","doi-asserted-by":"publisher","first-page":"e0181087","DOI":"10.1371\/journal.pone.0181087","article-title":"Generation and phenotypic characterization of Pde1a mutant mice","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"B279","doi-asserted-by":"publisher","first-page":"F1089","DOI":"10.1152\/ajprenal.00242.2012","article-title":"Insignificant effect of secretin in rodent models of polycystic kidney and liver disease","volume":"303","author":"Wang","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B280","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/sj.onc.1203548","article-title":"Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B282","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/embj.201385014","article-title":"Hormone-induced mitochondrial fission is utilized by brown adipocytes as an amplification pathway for energy expenditure","volume":"33","author":"Wikstrom","year":"2014","journal-title":"EMBO J."},{"key":"B283","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1042\/CS20210821","article-title":"Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype","volume":"135","author":"Wilson","year":"2021","journal-title":"Clin. Sci."},{"key":"B284","first-page":"8","article-title":"Effect of somatostatin on vasopressin-induced antidiuresis and renal cyclic AMP of rats","volume":"7","author":"Winkler","year":"1982","journal-title":"Min. Electrolyte Metab."},{"key":"B285","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00439-013-1378-0","article-title":"Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development","volume":"133","author":"Woo","year":"2014","journal-title":"Hum. Genet."},{"key":"B286","doi-asserted-by":"publisher","first-page":"14151","DOI":"10.1038\/s41598-017-14083-8","article-title":"Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models","volume":"7","author":"Woo","year":"2017","journal-title":"Sci. Rep."},{"key":"B287","doi-asserted-by":"publisher","first-page":"15238","DOI":"10.1038\/srep15238","article-title":"Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cyst growth in ADPKD","volume":"5","author":"Woo","year":"2015","journal-title":"Sci. Rep."},{"key":"B288","doi-asserted-by":"publisher","first-page":"F210","DOI":"10.1152\/ajprenal.90260.2008","article-title":"Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function","volume":"297","author":"Wu","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B289","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1038\/s41467-018-06898-4","article-title":"Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis","volume":"9","author":"Wu","year":"2018","journal-title":"Nat. Commun."},{"key":"B290","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1242\/dev.049437","article-title":"Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts","volume":"137","author":"Xia","year":"2010","journal-title":"Development"},{"key":"B291","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3892\/or.2014.3393","article-title":"Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway","volume":"32","author":"Xia","year":"2014","journal-title":"Oncol. Rep."},{"key":"B292","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00109-017-1606-5","article-title":"\u03b2-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1\/\u03b2-catenin signaling in mice","volume":"96","author":"Xu","year":"2018","journal-title":"J. Mol. Med."},{"key":"B293","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/FJC.0000000000001244","article-title":"Upregulation of periostin through CREB participates in myocardial infarction-induced myocardial fibrosis","volume":"79","author":"Xue","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B294","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B295","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0272-6386(97)90496-0","article-title":"Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease","volume":"30","author":"Yamaguchi","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"B296","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"key":"B297","doi-asserted-by":"publisher","first-page":"F944","DOI":"10.1152\/ajprenal.00387.2010","article-title":"Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells","volume":"299","author":"Yamaguchi","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B298","doi-asserted-by":"publisher","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B299","doi-asserted-by":"publisher","first-page":"11513","DOI":"10.1074\/jbc.RA118.001846","article-title":"A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector","volume":"293","author":"Yanda","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B300","doi-asserted-by":"publisher","first-page":"F997-F1004","DOI":"10.1152\/ajprenal.00186.2017","article-title":"An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease","volume":"313","author":"Yanda","year":"","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"17897","DOI":"10.1074\/jbc.M117.803775","article-title":"Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca(2+) in knock-out mouse models of polycystic kidney disease","volume":"292","author":"Yanda","year":"","journal-title":"J. Biol. Chem."},{"key":"B302","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1681\/ASN.2007070828","article-title":"Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease","volume":"19","author":"Yang","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B303","doi-asserted-by":"publisher","first-page":"G170-G178","DOI":"10.1152\/ajpgi.00492.2007","article-title":"Regulation of transforming growth factor beta-induced responses by protein kinase A in pancreatic acinar cells","volume":"295","author":"Yang","year":"","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B304","doi-asserted-by":"publisher","first-page":"23428","DOI":"10.1074\/jbc.M116.738591","article-title":"Physiological expression of AMPK\u03b32RG mutation causes wolff-Parkinson-white syndrome and induces kidney injury in mice.","volume":"291","author":"Yang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B305","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1523-1755.1998.00990.x","article-title":"Regulation of cAMP production in initial and terminal inner medullary collecting ducts","volume":"54","author":"Yasuda","year":"1998","journal-title":"Kidney Int."},{"key":"B306","doi-asserted-by":"publisher","first-page":"F677-F686","DOI":"10.1152\/ajprenal.00119.2017","article-title":"The regulatory 1\u03b1 subunit of protein kinase A modulates renal cystogenesis.","volume":"313","author":"Ye","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B307","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1681\/ASN.2015010057","article-title":"Modulation of polycystic kidney disease severity by phosphodiesterase 1 and 3 subfamilies","volume":"27","author":"Ye","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B308","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41598-019-38566-y","article-title":"Anti-microRNA screen uncovers miR-17 family within miR-17\u223c92 cluster as the primary driver of kidney cyst growth","volume":"9","author":"Yheskel","year":"2019","journal-title":"Sci. Rep."},{"key":"B309","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/s1097-2765(03)00388-5","article-title":"Inhibition of P-TEFb (CDK9\/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA","volume":"12","author":"Yik","year":"2003","journal-title":"Mol. Cell"},{"key":"B310","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1055\/s-0032-1316292","article-title":"Protein kinase A alterations in endocrine tumors","volume":"44","author":"Yu","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"B311","doi-asserted-by":"publisher","first-page":"e58871","DOI":"10.1371\/journal.pone.0058871","article-title":"Steviol reduces MDCK Cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradation","volume":"8","author":"Yuajit","year":"2013","journal-title":"PLoS One"},{"key":"B312","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bcp.2014.01.038","article-title":"Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease","volume":"88","author":"Yuajit","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B313","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1681\/ASN.2012050442","article-title":"TRPV4 dysfunction promotes renal cystogenesis in autosomal recessive polycystic kidney disease","volume":"24","author":"Zaika","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"dev158931","DOI":"10.1242\/dev.158931","article-title":"Polycystin 1 loss of function is directly linked to an imbalance in G-protein signaling in the kidney","volume":"145","author":"Zhang","year":"2018","journal-title":"Development"},{"key":"B315","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"","journal-title":"Mol. Cell. Biol."},{"key":"B316","doi-asserted-by":"publisher","first-page":"836","DOI":"10.14348\/molcells.2015.0263","article-title":"Structural studies of G protein-coupled receptors","volume":"38","author":"Zhang","year":"2015","journal-title":"Mol. Cells"},{"key":"B317","doi-asserted-by":"publisher","first-page":"778941","DOI":"10.3389\/fcell.2021.778941","article-title":"CREB ameliorates osteoarthritis progression through regulating chondrocytes autophagy via the miR-373\/METTL3\/TFEB Axis","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B318","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.cell.2020.07.043","article-title":"Phase separation of a PKA regulatory subunit controls cAMP compartmentation and oncogenic signaling","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"B319","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1128\/mcb.24.5.2169-2180.2004","article-title":"A transforming growth factor beta-induced Smad3\/Smad4 complex directly activates protein kinase A","volume":"24","author":"Zhang","year":"","journal-title":"Mol. Cell. Biol."},{"key":"B320","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2019.4188","article-title":"Mitochondrial electron transport chain, ROS generation and uncoupling (Review)","volume":"44","author":"Zhao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"B321","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/s0092-8674(00)80222-6","article-title":"The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism","volume":"89","author":"Zhong","year":"1997","journal-title":"Cell"},{"key":"B322","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1681\/ASN.2011050442","article-title":"Kidney injury accelerates cystogenesis via pathways modulated by heme oxygenase and complement","volume":"23","author":"Zhou","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B323","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/hmg\/ddt556","article-title":"SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplification caused by loss of polycystin-1","volume":"23","author":"Zhou","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B324","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/hmg\/ddv136","article-title":"Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B325","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B326","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000448693","article-title":"Dose-titrated vasopressin V2 receptor antagonist improves renoprotection in a mouse model for autosomal dominant polycystic kidney disease","volume":"44","author":"Zittema","year":"2016","journal-title":"Am. J. Nephrol."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.981963\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:54:54Z","timestamp":1662080094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.981963\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":325,"alternative-id":["10.3389\/fmolb.2022.981963"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.981963","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"article-number":"981963"}}